Literature DB >> 16860659

Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.

Weisan Chen1, James McCluskey.   

Abstract

The focusing of cellular immunity toward one, or just a few, antigenic determinant, even during immune responses to complex microorganisms or antigens, is known as immunodominance. Although described in many systems, the mechanisms of determinant immunodominance are only just beginning to be appreciated, especially in relation to the interplay between T cells of differing specificities and the interactions between T cells and the antigen-presenting cells (APCs). The outcome of these cellular interactions can lead to a form of immune suppression of one specificity by another-described as "immunodomination". The specific and detailed mechanisms involved in this process are now partly defined. A full understanding of all the factors that control immunodominance and influence immunodomination will help us to develop better viral and cancer vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860659     DOI: 10.1016/S0065-230X(06)95006-4

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  33 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

Review 2.  Hitting the Target: How T Cells Detect and Eliminate Tumors.

Authors:  Anthony E Zamora; Jeremy Chase Crawford; Paul G Thomas
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 3.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

Review 4.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  A simple mathematical model helps to explain the immunodominance of CD8 T cells in influenza A virus infections.

Authors:  Andreas Handel; Rustom Antia
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

6.  Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.

Authors:  Roberto Adamo; Alberto Nilo; Carole Harfouche; Barbara Brogioni; Simone Pecetta; Giulia Brogioni; Evita Balducci; Vittoria Pinto; Sara Filippini; Elena Mori; Marta Tontini; Maria Rosaria Romano; Paolo Costantino; Francesco Berti
Journal:  Glycoconj J       Date:  2014-09-26       Impact factor: 2.916

7.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 8.  Personalized peptide vaccines and their relation to other therapies in urological cancer.

Authors:  Takahiro Kimura; Shin Egawa; Hirotsugu Uemura
Journal:  Nat Rev Urol       Date:  2017-05-31       Impact factor: 14.432

9.  Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma.

Authors:  Sandra Iurescia; Daniela Fioretti; Pasquale Pierimarchi; Emanuela Signori; Manuela Zonfrillo; Giancarlo Tonon; Vito M Fazio; Monica Rinaldi
Journal:  J Biomed Biotechnol       Date:  2010-04-27

10.  Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses.

Authors:  Damien Zanker; Jason Waithman; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.